Loading publications…
The last 5 uploaded publications
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. J. Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher P. Cannon, Michael Clearfield, Helen M. Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Jonathan Emberson, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, Jordan Fulcher, John A. Fuller, Curt D. Furberg, David Gordon, Shinya Goto, Antonio M. Gotto, Heather Halls, Charlie Harper, C Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad (2019). Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet, 393(10170), pp. 407-415, DOI: 10.1016/s0140-6736(18)31942-1.
Article146 days agoEffect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, Philippe Gabríel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, KyungAh Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F. Watson, W. Douglas Weaver, Patrick W. Serruys, Christopher P. Cannon (2014). Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome. JAMA, 312(10), pp. 1006-1006, DOI: 10.1001/jama.2014.11061.
Article146 days agoStudy design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Patrick W. Serruys, Philippe Gabríel Steg, Judith S. Hochman, Aldo P. Maggioni, Christoph Bode, Donald W. Weaver, Joel L. Johnson, Greg Cicconetti, Mary Ann Lukas, Elizabeth Tarka, Christopher P. Cannon (2011). Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. American Heart Journal, 162(4), pp. 613-619.e1, DOI: 10.1016/j.ahj.2011.07.018.
Article146 days ago